Document is current

Any future updates will be listed below

Correction: Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: a clinical trial

Crossref DOI link: https://doi.org/10.1186/s13287-024-04044-0

Published Online: 2024-11-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark